Insider · CIK 0001591467

Butler John P.

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001591467

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-06	AKBAAkebia Therapeutics, Inc.M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	+350K sh	$0.63	+$221K	3,718,564
2026-08-06	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)M Exercise/Conversion	Director, CEO and President	MExercise/Conversion	−350K sh	—	—	525,000
2026-03-04	AKBAAkebia Therapeutics, Inc.P Purchase	Director, CEO and President	PPurchase	+69.3K sh	$1.25	+$86.6K	3,367,064
2026-02-02	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−46.7K sh	$1.39	−$64.9K	3,417,189
2026-02-02	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−115K sh	$1.39	−$160K	3,206,233
2026-02-02	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−96.1K sh	$1.39	−$134K	3,321,124
2026-02-02	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−83.7K sh	$1.39	−$116K	3,297,794
2026-02-02	AKBAAkebia Therapeutics, Inc.A Award	Director, CEO and President	AAward	+175K sh	$1.41	+$247K	3,381,483
2026-01-30	AKBAAkebia Therapeutics, Inc.A Award	Director, CEO and President	AAward	+743K sh	—	—	3,463,849
2026-01-30	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, CEO and President	AAward	+1.12M sh	—	—	1,115,000
2025-03-03	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−46.4K sh	$1.83	−$84.9K	2,557,921
2025-02-03	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−98K sh	$2.10	−$206K	2,604,330
2025-02-03	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−46.3K sh	$2.10	−$97.2K	2,702,312
2025-01-31	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, CEO and President	AAward	+1.05M sh	—	—	1,051,400
2025-01-31	AKBAAkebia Therapeutics, Inc.A Award	Director, CEO and President	AAward	+701K sh	—	—	2,748,580
2025-01-31	AKBAAkebia Therapeutics, Inc. · Performance Stock UnitsA Award	Director, CEO and President	AAward	+351K sh	—	—	350,500
2024-02-29	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−46.6K sh	$1.58	−$73.6K	2,044,580
2024-02-27	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−37.7K sh	$1.52	−$57.4K	2,091,150
2024-02-01	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−46.5K sh	$1.68	−$78.1K	2,128,883
2024-01-31	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, CEO and President	AAward	+905K sh	—	—	905,200
2024-01-31	AKBAAkebia Therapeutics, Inc.A Award	Director, CEO and President	AAward	+604K sh	—	—	2,175,372
2023-10-10	Zynerba Pharmaceuticals, Inc.U Disposition from Tender	Director	UDisposition from Tender	−32.9K sh	—	—	47,824
2023-10-10	Zynerba Pharmaceuticals, Inc.U Disposition from Tender	Director	UDisposition from Tender	−47.8K sh	—	—	0
2023-10-10	Zynerba Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−34.7K sh	—	—	0
2023-10-10	Zynerba Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−71.7K sh	—	—	0
2023-06-14	Zynerba Pharmaceuticals, Inc.S Sale	Director	SSale	−115 sh	$0.35	−$40.032	80,765
2023-06-13	Zynerba Pharmaceuticals, Inc.A Award	Director	AAward	+47.8K sh	—	—	80,880
2023-06-13	Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+71.7K sh	—	—	71,736
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−6,370 sh	$0.88	−$5,589.675	1,568,872
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−47.2K sh	$0.88	−$41.5K	1,575,242
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−38.3K sh	$0.88	−$33.6K	1,622,481
2023-02-27	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−38.6K sh	$0.81	−$31.4K	1,660,740
2023-01-31	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	Director, CEO and President	AAward	+875K sh	—	—	875,000
2023-01-31	AKBAAkebia Therapeutics, Inc. · Stock Appreciation RightA Award	Director, CEO and President	AAward	+635K sh	—	—	635,313
2023-01-31	AKBAAkebia Therapeutics, Inc.A Award	Director, CEO and President	AAward	+293K sh	—	—	1,699,372
2022-06-14	Zynerba Pharmaceuticals, Inc.S Sale	Director	SSale	−53 sh	$1.01	−$53.53	33,056
2022-06-14	Zynerba Pharmaceuticals, Inc.A Award	Director	AAward	+23.1K sh	—	—	33,109
2022-06-14	Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+34.7K sh	—	—	34,663
2022-03-01	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−4,131 sh	$2.17	−$8,967.162	1,403,247
2022-03-01	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−24.8K sh	$2.17	−$53.9K	1,432,409
2022-03-01	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−25K sh	$2.17	−$54.3K	1,407,378
2022-02-28	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−25.1K sh	$2.15	−$54K	1,164,095
2022-02-28	AKBAAkebia Therapeutics, Inc.A Award	Director, CEO and President	AAward	+293K sh	—	—	1,457,220
2022-02-28	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	Director, CEO and President	AAward	+740K sh	—	—	739,700
2021-08-03	Zynerba Pharmaceuticals, Inc.A Award	Director	AAward	+5,000 sh	—	—	10,000
2021-08-03	Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2021-04-01	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−4,109 sh	$3.40	−$14K	1,152,153
2021-03-16	AKBAAkebia Therapeutics, Inc.A Award	Director, CEO and President	AAward	+39.5K sh	—	—	1,156,262
2021-03-01	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−24.7K sh	$3.40	−$83.8K	1,116,742
2021-03-01	AKBAAkebia Therapeutics, Inc.S Sale	Director, CEO and President	SSale	−25.3K sh	$3.40	−$86K	1,141,416

Recent filings

Accepted (ET)
Aug 104
Butler John P.0001591467-26-000004
SEC(opens sec.gov)
Mar 54
Butler John P.0001591467-26-000003
SEC(opens sec.gov)
Feb 44
Butler John P.0001591467-26-000002
SEC(opens sec.gov)
Feb 34
Butler John P.0001591467-26-000001
SEC(opens sec.gov)
Mar 44
Butler John P.0001562180-25-001998
SEC(opens sec.gov)
Feb 44
Butler John P.0001562180-25-000917
SEC(opens sec.gov)
Mar 14
Butler John P.0001562180-24-002021
SEC(opens sec.gov)
Feb 294
Butler John P.0001562180-24-001992
SEC(opens sec.gov)
Feb 24
Butler John P.0001562180-24-000971
SEC(opens sec.gov)

Companies

Address

C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET

CAMBRIDGE, MA, 02142